Life Sciences Push Agilent Q2 Revenues up 32 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies today reported a 32 percent jump in fiscal second-quarter revenues year over year, with its Life Sciences segment seeing a 39 percent spike.

The company reported total revenues of $1.68 billion for the three months ended April 30, up from $1.27 billion a year ago, beating Wall Street expectation of $1.6 billion. Excluding the effects of acquisitions and divestitures, revenues rose 21 percent in the quarter year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: cell-free DNA from tumors is shorter than DNA from healthy cells, type 2 diabetes-related loci, and more.

Genetic analysis confirms that blood found on leaves collected near Marche-les-Dames some 80 years ago belongs to King Albert I of Belgium.

Researchers in the US begin to seek participants for the 1 million-person precision medicine cohort, the New York Times reports.

A new report indicates that women are underrepresented among US patent holders.